[go: up one dir, main page]

PL2968478T3 - Kompozycje i sposoby do leczenia karboksyhemoglobinemii - Google Patents

Kompozycje i sposoby do leczenia karboksyhemoglobinemii

Info

Publication number
PL2968478T3
PL2968478T3 PL14769521T PL14769521T PL2968478T3 PL 2968478 T3 PL2968478 T3 PL 2968478T3 PL 14769521 T PL14769521 T PL 14769521T PL 14769521 T PL14769521 T PL 14769521T PL 2968478 T3 PL2968478 T3 PL 2968478T3
Authority
PL
Poland
Prior art keywords
carboxyhemoglobinemia
compositions
treatment
methods
Prior art date
Application number
PL14769521T
Other languages
English (en)
Inventor
Mark T. Gladwin
Jesus TEJERO BRAVO
Original Assignee
University Of Pittsburgh - Of The Commonwealth System Of Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Pittsburgh - Of The Commonwealth System Of Higher Education filed Critical University Of Pittsburgh - Of The Commonwealth System Of Higher Education
Publication of PL2968478T3 publication Critical patent/PL2968478T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL14769521T 2013-03-15 2014-03-11 Kompozycje i sposoby do leczenia karboksyhemoglobinemii PL2968478T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361799155P 2013-03-15 2013-03-15
US201361834035P 2013-06-12 2013-06-12
EP14769521.7A EP2968478B1 (en) 2013-03-15 2014-03-11 Compositions and methods for the treatment of carboxyhemoglobinemia
PCT/US2014/023180 WO2014150413A1 (en) 2013-03-15 2014-03-11 Compositions and methods for the treatment of carboxyhemoglobinemia

Publications (1)

Publication Number Publication Date
PL2968478T3 true PL2968478T3 (pl) 2019-01-31

Family

ID=51580761

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14769521T PL2968478T3 (pl) 2013-03-15 2014-03-11 Kompozycje i sposoby do leczenia karboksyhemoglobinemii

Country Status (9)

Country Link
US (5) US20160039910A1 (pl)
EP (2) EP2968478B1 (pl)
CN (2) CN105209060B (pl)
AU (2) AU2014237216B2 (pl)
CA (1) CA2904397C (pl)
DK (1) DK2968478T3 (pl)
ES (1) ES2691086T3 (pl)
PL (1) PL2968478T3 (pl)
WO (1) WO2014150413A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2968478T3 (pl) 2013-03-15 2019-01-31 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Kompozycje i sposoby do leczenia karboksyhemoglobinemii
EP3458038B1 (en) * 2016-05-19 2025-12-10 University of Pittsburgh- Of the Commonwealth System of Higher Education Reduced oxygen carriers and their use for the treatment of carboxyhemoglobinemia
CN108892720B (zh) * 2018-07-19 2021-01-22 南华大学 一种神经红突变体蛋白及其制备方法
CN109748972B (zh) * 2019-01-31 2021-12-03 泉州师范学院 一种细胞珠蛋白-人源乳铁蛋白肽融合蛋白、基因及应用
CA3135797A1 (en) * 2019-04-02 2020-10-08 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Modified hemoglobin molecules and uses thereof
US12228565B2 (en) * 2021-06-16 2025-02-18 Instrumentation Laboratory Company Blood cell lysis compositions and uses thereof
CN116236562A (zh) * 2022-12-30 2023-06-09 广州震达生物医药技术有限公司 细胞珠蛋白在制备预防和/或治疗糖尿病的药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW381022B (en) * 1993-08-16 2000-02-01 Hsia Jen Chang Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute
JP2004537539A (ja) * 2001-06-29 2004-12-16 スローン − ケッタリング インスティチュート フォー キャンサー リサーチ ヒトグロビン遺伝子をコードするベクターとその異常ヘモグロビン血症の治療におけるその使用
WO2007014275A2 (en) * 2005-07-26 2007-02-01 Sangamo Biosciences, Inc. Targeted integration and expression of exogenous nucleic acid sequences
CN101348786B (zh) * 2007-07-20 2011-05-11 谭孟群 一种人β珠蛋白基因及其重组腺相关病毒载体
WO2009013559A1 (en) * 2007-07-23 2009-01-29 Cellectis Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof
JP2010194475A (ja) 2009-02-26 2010-09-09 Doshisha 一酸化炭素除去剤
US9114109B2 (en) * 2009-06-16 2015-08-25 University of Pittsburgh—of the Commonwealth System of Higher Education Five-coordinate neuroglobin and use thereof as a blood substitute
CN102175682B (zh) * 2010-03-08 2013-02-20 中国人民解放军军事医学科学院放射与辐射医学研究所 重组人源脑红蛋白的生物活性检测方法及其用途
CN102743456B (zh) * 2011-04-19 2015-10-21 河北以岭医药研究院有限公司 一种中药组合物在制备防治一氧化碳中毒迟发性脑病的药物中的应用
PL2968478T3 (pl) 2013-03-15 2019-01-31 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Kompozycje i sposoby do leczenia karboksyhemoglobinemii

Also Published As

Publication number Publication date
HK1220374A1 (en) 2017-05-05
EP3461492B1 (en) 2025-04-30
ES2691086T3 (es) 2018-11-23
EP2968478B1 (en) 2018-08-15
US20240083979A1 (en) 2024-03-14
US11845785B2 (en) 2023-12-19
AU2017276274A1 (en) 2018-01-18
CN109498802B (zh) 2021-11-09
AU2017276274B2 (en) 2019-06-13
AU2014237216B2 (en) 2017-12-21
WO2014150413A1 (en) 2014-09-25
US10421800B2 (en) 2019-09-24
EP2968478A4 (en) 2016-09-07
EP3461492A1 (en) 2019-04-03
AU2014237216A1 (en) 2015-10-08
CN109498802A (zh) 2019-03-22
US20210070841A1 (en) 2021-03-11
US20160039910A1 (en) 2016-02-11
CN105209060B (zh) 2018-12-07
US20180118810A1 (en) 2018-05-03
CN105209060A (zh) 2015-12-30
EP2968478A1 (en) 2016-01-20
US20190389937A1 (en) 2019-12-26
US12269866B2 (en) 2025-04-08
CA2904397A1 (en) 2014-09-25
DK2968478T3 (en) 2018-11-12
CA2904397C (en) 2019-12-17
US10851153B2 (en) 2020-12-01

Similar Documents

Publication Publication Date Title
IL273090B (en) Methods and preparations for the treatment of cancer
IL286759A (en) Therapeutic methods and preparations
SG11201601412XA (en) Compositions and methods for the treatment of presbyopia
GB201320723D0 (en) Composition and methods of treatment
IL265876A (en) Preparations that include 15-ohepa and methods of using them
EP2958936A4 (en) METHOD AND COMPOSITIONS FOR TREATING CORI DISEASE
SG10201708595YA (en) Cenicriviroc compositions and methods of making and using the same
IL239921A0 (en) Preparations containing solutions in solid state and their use for the treatment of pain
PT3021839T (pt) Composições para o tratamento da fibrose
SG10201710538XA (en) Compositions and methods for treating skin
PL2968478T3 (pl) Kompozycje i sposoby do leczenia karboksyhemoglobinemii
IL243022B (en) Compositions and methods for post-harvest treatment
PT3038596T (pt) Composições e métodos para a remoção de tatuagens
EP2994147A4 (en) Compositions and methods for the treatment of tinnitus
PL2992094T3 (pl) Kompozycje i sposoby leczenia cukrzycy typu 1
GB201300628D0 (en) Compositions comprising 15-OHEPA and methods of using the same
GB201319255D0 (en) Therapeutic compositions and methods
AU2013901658A0 (en) Compositions and methods for the treatment of tinnitus